Determination of Utility of Intergluteal Cleft as Landmark for Neuraxial Midline in Obstetrics
CLEFT
Determination of the Utility of the Intergluteal Cleft as a Landmark for nEuraxial Midline identiFication in obsteTric Patients
1 other identifier
observational
99
1 country
1
Brief Summary
Our aim is to investigate whether a novel landmark, the groove between the buttocks or the intergluteal cleft, can facilitate the identification of the neuraxial midline in obstetric patients when compared to ultrasound as the reference standard for the determination of this midline
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2022
CompletedFirst Posted
Study publicly available on registry
August 9, 2023
CompletedStudy Start
First participant enrolled
December 7, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2024
CompletedFebruary 28, 2024
February 1, 2024
9 months
November 22, 2022
February 27, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Horizontal distance between intergluteal cleft and neuraxial midline
One horizontal distance and hence one primary outcome
12 months
Secondary Outcomes (3)
Difference in horizontal distance stratified by body mass index
12 months
Difference in horizontal distance stratified by presence of pre-eclampsia
12 months
Difference in horizontal distance stratified by presence of pregnancy induced hypertension
12 months
Study Arms (1)
Study Group
Each patient will be requested to adopt a standardised upright position. First, two of the investigators will use a spirit level ruler and ink pen to agree upon and visibly mark the horizontal intercristal line on the back of the patient. Second, investigator B will leave the room, and investigator A will make a vertical mark with an ultraviolet pen denoting the intersection of the inferior aspect of the intergluteal cleft and the horizontal intercristal line. Third, investigator A will then leave the room, and investigator B will return to the room to make a vertical mark with an ink pen representing the intersection of the neuraxial midline, as established with the transverse spinous process view on ultrasound, and the horizontal intercristal line. After these two vertical marks have been made at the level of the intercristal line, the horizontal distance between them will be measured in mm by these same two investigators
Interventions
Marking of intersection between inferior aspect of the intergluteal cleft and the horizontal intercristal line
Marking of intersection between the neuraxial midline, as established with the transverse spinous process view on ultrasound, and the horizontal intercristal line
The horizontal distance between these two vertical marks will be measured at the level of the intercristal line
Eligibility Criteria
Pregnant patients
You may qualify if:
- Female
- years of age or older
- Gestation of 37 weeks or above
You may not qualify if:
- Acute or chronic confusional state
- Allergy to ultrasound gel
- Positive for COVID-19 and/or presence of symptoms consistent with SARS-Cov-2, such as anosmia, cough or fever
- History of previous surgery to the spine
- Scoliosis
- Unable to speak and/or understand English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guy's Hospital, Great Maze Pond
London, SE1 9RT, United Kingdom
Study Officials
- STUDY CHAIR
Gill Arbane, BSc
Guys' & St Thomas' NHS Foundation Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CROSSOVER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 22, 2022
First Posted
August 9, 2023
Study Start
December 7, 2023
Primary Completion
September 1, 2024
Study Completion
September 1, 2024
Last Updated
February 28, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share